We are celebrating a major milestone in our digital communications! A recent Facebook post about the pioneering cancer vaccine trial at Lancashire Clinical Research Facility has reached more than 800, 000 people - the highest engagement ever recorded on our Trust's social media channels. The post highlighted our involvement in a national trial fast-tracking patients with advanced head and neck cancers into a cutting-edge mRNA vaccine study. It featured powerful quotes from Dr Dennis Hadjiyiannakis and patient advocate Chris Curtis and showcased the Trust's role in supporting the NHS Cancer Vaccine Launch Pad programme.
This incredible reach reflects the public's growing interest in innovative cancer treatments and the Trust's commitment to advancing research that offers hope and better outcomes for patients.
A huge thank you to everyone involved in delivering this impactful story - from our research teams to our communications colleagues.
